Skip to main content
User Image

Shaun Sabico

Associate Professor

Associate Professor and Deputy Director

كلية العلوم
Chair for Biomarkers of Chronic Diseases, Biochemistry Department, College of Science, KSU
publication
Journal Article
2024

Evidence-Based Guideline for the management of osteoporosis in men

Historically, osteoporosis has been viewed as a disease of women, with research, trials of interventions and guidelines predominantly focused as such. It is apparent, however, that this condition causes a substantial health burden in men also, and that its assessment and management must ultimately be addressed across both sexes. In this article, an international multidisciplinary working group of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases presents GRADE-assessed recommendations for the diagnosis, monitoring and treatment of osteoporosis in men. The recommendations are based on a comprehensive review of the latest research related to diagnostic and screening approaches for osteoporosis and its associated high fracture risk in men, covering disease burden, appropriate interpretation of bone densitometry (including the use of a female reference database for densitometric diagnosis in men) and absolute fracture risk, thresholds for treatment, and interventions that can be used therapeutically and their health economic evaluation. Future work should specifically address the efficacy of anti-osteoporosis medications, including denosumab and bone-forming therapies.

Publisher Name
Springer Nature
Publishing City
London
Volume Number
20
Issue Number
4
Magazine \ Newspaper
Nature Rheumatology
Pages
241-251
more of publication
publications

Background

Dietary fiber plays a crucial role in disease prevention through multiple protective mechanisms. While previous reviews have examined its health effects,…

by Veronese N, Gianfredi V, Solmi M, Barbagallo M, Dominguez LJ, Mandalà C, Di Palermo C, Carruba L, Solimando L, Stubbs B, Castagna A, Stefania M, Zanetti M, Al-Daghri N, Sabico S, Nucci D, Gosling C, Fontana L
2025
Published in:
Elsevier
publications

Background

by Wani K, Kumar B, Amer OE, Al-Daghri NM, Sabico S
2025
Published in:
Springer Nature
publications

Background: Fibroblast growth factor-21 (FGF21) and omentin-1 have been recognized as potent antidiabetic agents with potential hepatoprotective activity.

by Alenazi MM, Sabico S, Alnaami AM, Wani K, Hussain SD, Al-Daghri NM
2025
Published in:
Springer Nature